International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 1 , Pages 44-51 , January 2005

Randomized trial of high- and low-source strength 125I prostate seed implants

Presented at the 45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Salt Lake City, UT, October 19–23, 2003.

  • Vrinda Narayana, Ph.D.

      Affiliations

    • Providence Hospital, Southfield, MI USA
    • University of Michigan, Ann Arbor, MI, USA
    • Corresponding Author InformationReprint requests to: Vrinda Narayana, Ph.D., Providence Hospital, 22301 Foster Winter Dr., Ste. 100, Southfield, MI 48009, USA. Tel: (248) 849-8622; Fax: (248) 849-8448
    • ,
  • Sara Troyer, B.S.

      Affiliations

    • University of Michigan, Ann Arbor, MI, USA
    • ,
  • Vicki Evans

      Affiliations

    • University of Michigan, Ann Arbor, MI, USA
    • ,
  • Raymond J. Winfield, M.D.

      Affiliations

    • Providence Hospital, Southfield, MI USA
    • ,
  • Peter L. Roberson, Ph.D.

      Affiliations

    • University of Michigan, Ann Arbor, MI, USA
    • ,
  • Patrick W. McLaughlin, M.D.

      Affiliations

    • Providence Hospital, Southfield, MI USA
    • University of Michigan, Ann Arbor, MI, USA

Received 26 January 2004 ,Revised 27 April 2004 ,Accepted 3 May 2004.

References 

  1. Merrick GS, Wallner KE, Butler WM. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol. 2003;169:1643–1652
  2. Stock RG, Stone NN, Tabert A, et al.  A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 1998;41:101–108
  3. Potters L, Cao Y, Calugaru E, et al.  A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2001;50:605–614
  4. Merrick GS, Butler WM, Galbreath RW, et al.  Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer. Int J Radiat Oncol Biol Phys. 2001;51:41–48
  5. McLaughlin PW, Narayana V, Dworzanin ME, et al.  Permanent implantation of 125-I sources in the prostate (Radical limits of simplicity). Radiology. 1999;213:839–844
  6. D'Souza WD, Meyer RR. Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans. Int J Radiat Oncol Biol Phys. 2001;51:1120–1130
  7. Sloboda RS, Pedersen JE, Halperin R. Is there a preferred strength for regularly spaced 125I seeds in inverse-planned prostate implants?. Int J Radiat Oncol Biol Phys. 2003;55:234–244
  8. Merrick GS, Butler WM, Dorsey AT, et al.  The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys. 1999;44:1111–1117
  9. Lee WR, Roach M, Michalski J, et al.  Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys. 2002;54:457–461
  10. McLaughlin PM, Narayana V, Drake DG, et al. A comparison of MRI pulse sequences in defining the prostate volume post permanent implant. Int J Radiat Oncol Biol Phys 2002;54:703–711
  11. Dubois DF, Prestidge BR, Hotchkiss LA, et al.  Intraobserver and interobserver variability of MR imaging and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology. 1998;207:785–789
  12. Amdur RJ, Gladstone D, Leopold KA, et al.  Prostate seed implant quality assessment using MR and CT image fusion. Int J Radiat Oncol Biol Phys. 1999;43:67–72
  13. Fraass BA, McShan DL. 3D treatment planning I: Overview of a clinical planning system. In:  Bruinvis IAD editors. The use of computers in radiation therapy. Amsterdam, The Netherlands: Elsevier; 1987;p. 273–276
  14. McLaughlin PM, Narayana V, Kessler M, et al. The use of mutual information in registration of CT and MRI datasets post permanent implant. Brachytherapy 2004; in press
  15. Sidhu S, Morris WJ, Spadinger I, et al.  Prostate brachytherapy post-implant dosimetry (A comparison of prostate quadrants—American Brachytherapy Society proceedings). Int J Radiat Oncol Biol Phys. 2002;52:544–552

PII: S0360-3016(04)00776-X

doi: 10.1016/j.ijrobp.2004.05.001

International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 1 , Pages 44-51 , January 2005

Article Tools

* Image Usage & Resolution